Where & When

Cicletanine (CCL) Timeline

1983



Diuretic effect, Prostacyclin
1st PubMed, Lancet

1986



Launch in France
Robust safety profile (1983 - current)

  • > 10,000 clinical-trials patients

  • 2 million post-launch patient years; serious adverse events rare (< 1 / 100,000 patient-months)

1989



CCL vs. salt - sensitive hypertension (SSH)

1991



CCL vs. SSH & sympathetic overdrive

1995



CCL vs. sympathetic overdrive

1996



Japan

Basal generation of nitric oxide (NO) in the vascular wall of Dahl S rats

2001



Japan, France, US

Papers report nitric oxide, antioxidant activity; improved endothelial function

2009



BK channel activity

(Unpublished research) Relevant to vascular aging, Alzheimer’s; patent filed, 2023

2013



Endothelial-function activity confirmed: eNOS activation

US research confirms eNOS and PKG activation